<- Go Home

Inogen, Inc.

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Market Cap

$191.8M

Volume

232.9K

Cash and Equivalents

$93.1M

EBITDA

-$9.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$155.8M

Profit Margin

44.31%

52 Week High

$9.13

52 Week Low

$5.34

Dividend

N/A

Price / Book Value

1.05

Price / Earnings

-7.65

Price / Tangible Book Value

1.34

Enterprise Value

$98.6M

Enterprise Value / EBITDA

-16.87

Operating Income

-$30.1M

Return on Equity

13.07%

Return on Assets

-6.33

Cash and Short Term Investments

$110.2M

Debt

$16.9M

Equity

$182.9M

Revenue

$351.5M

Unlevered FCF

-$3.0M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches